Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06277999 · ClinicalTrials.gov registry record
C.Difficile Observational Study
A clinical trial, sponsored by AstraZeneca.
- Completed
- Registry status
- 7
- Enrollment target
NCT06277999 is a clinical trial that has completed, run by AstraZeneca. The registered enrollment target is 7 participants.
The verdict
NCT06277999 has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
D8820C00001 is an exploratory, non-interventional, unblinded, observational study evaluating the acceptability, feasibility and performance of methods to collect, transport and test biospecimens in participants ≥ 18 years of age with an active CDI. Participants will also be monitored for recurring episodes of diarrhea and will need to complete validated PROs and study evaluation questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2024-04-22 |
| Est. Completion | 2024-12-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06277999
The ClinicalTrials.gov registry entry for NCT06277999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06277999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06277999 about?
NCT06277999 is a clinical study titled "C.Difficile Observational Study". D8820C00001 is an exploratory, non-interventional, unblinded, observational study evaluating the acceptability, feasibility and performance of methods to collect, transport and test biospecimens in participants ≥ 18 years of age with an active CDI. Participants will also be monitored for recurring e...
What is the current status of trial NCT06277999?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2024-04-22. Estimated completion is 2024-12-17.
Who is sponsoring clinical trial NCT06277999?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.